SCHEMBL1883483

SCHEMBL1883483

CC(C)C(=O)NC1CCc2c(c3cc(C#N)ccc3n2Cc2cccc([N+](=O)[O-])c2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
PLA2G2A P14555 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CCR2 P41597 1/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
NOX4 Q9NPH5 1/20 0.36
KRAS P01116 2/20 0.36
RORC P51449 1/20 0.36
CACNB4 O00305 1/20 0.35
CACNA1A O00555 1/20 0.35
CACNA1G O43497 1/20 0.35
CACNG3 O60359 1/20 0.35
CACNA1F O60840 1/20 0.35
CACNA1H O95180 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1876344 0.87 PTGDR2 (0.40) MTNR1AMTNR1BPTGDR2PLA2G2ACCR2
SCHEMBL1879169 0.87 PTGDR2 (0.47) MTNR1AMTNR1BPTGDR2RORC
SCHEMBL1880293 0.87 PTGDR2 (0.47) MTNR1AMTNR1BPTGDR2RORC
SCHEMBL1874209 0.87 PTGDR2 (0.47) MTNR1AMTNR1BPTGDR2RORC
SCHEMBL1880816 0.86 PTGDR2 (0.41) MTNR1AMTNR1BPTGDR2SIGMAR1ALDH1A1
SCHEMBL1885361 0.86 PTGDR2 (0.46) MTNR1AMTNR1BPTGDR2PLA2G2AKMT2A
SCHEMBL1881903 0.82 PTGDR2 (0.39) MTNR1AMTNR1BPTGDR2RORC
SCHEMBL1887084 0.81 PTGDR2 (0.43) MTNR1AMTNR1BPTGDR2RORC
SCHEMBL1879437 0.81 MTNR1A (0.49) MTNR1AMTNR1BPTGDR2KMT2ARORC
SCHEMBL1875284 0.81 PTGDR2 (0.42) MTNR1AMTNR1BPTGDR2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7935722-B2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-05-03 US disclosed
EP-1902026-B1 TETRAHYDROCARBAZOLE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS (SARM) LILLY CO ELI (US) 2010-02-17 EP disclosed
US-20100022550-A1 TETRAHYDROCARBAZOLE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS CELLECTIS (FR) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022550-A1 TETRAHYDROCARBAZOLE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS AR, SHBG, CYP17A1 MTNR1A 1610/4885MTNR1B 1349/4885PTGDR2 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.